Company-friendly debt solution will support expansion of the rapidly-growing innovative software company
Strategikon Pharma, a leading provider of clinical trial planning and outsourcing software solutions, has secured a growth loan from Decathlon Capital Partners. The multi-million dollar investment package will be used to expand Strategikon’s sales and client support teams to meet growing market demand for its innovative Clinical Maestro platform.
Headquartered in San Francisco, Strategikon’s technology streamlines and simplifies the complex process of clinical trial planning, budgeting, and outsourcing for biopharma sponsors and service providers. Strategikon improves transparency, efficiency, and collaboration, thereby helping companies optimize their outsourcing strategies and bring therapies to patients faster. Details of the transaction were not disclosed.
Anca Copaescu, Founder and CEO of Strategikon, said the company is focused on transforming clinical trial operations through smarter, technology-driven solutions. “We created Strategikon to eliminate the inefficiencies and complexities that have long challenged clinical trial planning and outsourcing,” Copaescu said. “Our mission is to empower biopharma companies and service providers with intuitive tools that streamline processes, improve collaboration, and ultimately accelerate the delivery of life-changing therapies to patients.”
Strategikon will repay its investment from Decathlon Capital Partners through its future revenues, thanks to the dilution-free, company-friendly funding package.
John Borchers, Managing Director of Decathlon Capital Partners, praised Strategikon’s innovative approach to clinical trial management. “Strategikon is helping modernize a critical part of the biopharma industry with smart, scalable technology,” Borchers said. “We are excited to support their expansion as they deliver greater value to sponsors and service providers across the clinical trial ecosystem.”
Health Technology Insights: RAREMED ACHIEVES NATION’S HIGHEST PATIENT SATISFACTION SCORE
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
